Virpax Pharmaceuticals Inc (NASDAQ:VRPX) currently has a daily average trading volume of 338.02K but it saw 1238927 shares traded in last market. With a market cap of 1.52M USD, the company’s current market price of $1.22 came falling about -4.69 while comparing to the previous closing price of $1.28. In past 52 weeks, the stock remained buoying in the range of price level as high as $105.99 and as low as $1.08. In the recent trading on the day, stock has struck highest price mark of $1.2 while lowest mark touched by it was $1.7778.
Taking a look at 20-day trading activity of Virpax Pharmaceuticals Inc (VRPX) gives us an average price of $2.9180, while its current price level is -98.85% below from 52-week high level whereas it is 12.80% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.2593 while that of 200 days or SMA-200 reads an average of $14.7433. A closer look into the stock’s movement over the week reveals that its volatility is standing at 23.57% during that period while stretching the period over a month that decreases to 17.15%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 15.83 which implies that the stock is in oversold territory.
Over the week, VRPX’s stock price is moving -21.29% down while it is -74.32% when we observe its performance for the past one month. Year-to-date it is -87.15% down and over the past year, the stock is showing a downside performance of -98.84%.
The company is expected to be releasing its next quarterly report on 2025-Mar-02, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Virpax Pharmaceuticals Inc’s total number of outstanding shares is 1.24M with 0.96% of that held by the insiders while 0.41% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -2364.82%. Stock’s beta reads 1.41. Its return on asset (ROA) is -215.80% on average.
